AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
DOSE INTENSIFICATION OF EPIDOXORUBICIN AND CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER - A RANDOMIZED STUDY WITH 2 SCHEDULES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
Authors: STOGER H SAMONIGG H KRAINER M PLOSZCZYNSKI M NIRNBERGER G MACA S HEHENWARTER W WIRTH M SCHULLER J VAVRA N SCHEITHAUER W KORNEK G STIERER M ZIELINSKI CC
Citation: H. Stoger et al., DOSE INTENSIFICATION OF EPIDOXORUBICIN AND CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER - A RANDOMIZED STUDY WITH 2 SCHEDULES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, European journal of cancer, 34(4), 1998, pp. 482-488
INACTIVATING MUTATIONS IN AN SH2 DOMAIN-ENCODING GENE IN X-LINKED LYMPHOPROLIFERATIVE SYNDROME
Authors: NICHOLS KE HARKIN DP LEVITZ S KRAINER M KOLQUIST KA GENOVESE C BERNARD A FERGUSON M ZUO L SNYDER E BUCKLER AJ WISE C ASHLEY J LOVETT M VALENTINE MB LOOK AT GERALD W HOUSMAN DE HABER DA
Citation: Ke. Nichols et al., INACTIVATING MUTATIONS IN AN SH2 DOMAIN-ENCODING GENE IN X-LINKED LYMPHOPROLIFERATIVE SYNDROME, Proceedings of the National Academy of Sciences of the United Statesof America, 95(23), 1998, pp. 13765-13770
COOPERATIVE STUDY OF SOFT-TISSUE SARCOMA - FIRST RESULTS
Authors: BRODOWICZ T WILTSCHKE C KRAINER M RITSCHL P WINDHAGER R DOBROWSKY W POTTER R AMMAN G LANG S SALZERKUNTSCHIK M KOTZ R ZIELINSKI CC
Citation: T. Brodowicz et al., COOPERATIVE STUDY OF SOFT-TISSUE SARCOMA - FIRST RESULTS, European journal of cancer, 33, 1997, pp. 513-513
DOUBLING EPIRUBICIN DOSE INTENSITY (100 MG M(2) VERSUS 50 MG/M(2)) INTHE FEC REGIMEN SIGNIFICANTLY INCREASES RESPONSE RATES - AN INTERNATIONAL RANDOMIZED PHASE-III STUDY IN METASTATIC BREAST-CANCER/
Authors: BRUFMAN G COLAJORI E GHILEZAN N LASSUS M MARTONI A PEREVODCHIKOVA N TOSELLO C VIARO D ZIELINSKI C KRAINER M SALZER H SCHULLER J DITTRICH C SCHEITHAUER W ZAMAGNI C AMBROSINI G COLUCCI G GENTILINI P ZANIBONI A PACINI P BIANCO R MUSTACCHI G DAPRILE M DEMATTEIS A OLIVEIRA C JORDAAN J GUDGEON A VANZYL J RAKOWSKY E INBAR M RATH P COHEN Y SHANI A FRIED G HEGG R NETO AB BADER G BRAGA RF VITOC C PUERTO VML VALLE AE SALAZAR JD SANCHEZ JC VILLELA GM FOUNTZILAS G
Citation: G. Brufman et al., DOUBLING EPIRUBICIN DOSE INTENSITY (100 MG M(2) VERSUS 50 MG/M(2)) INTHE FEC REGIMEN SIGNIFICANTLY INCREASES RESPONSE RATES - AN INTERNATIONAL RANDOMIZED PHASE-III STUDY IN METASTATIC BREAST-CANCER/, Annals of oncology, 8(2), 1997, pp. 155-162
A RANDOMIZED ADJUVANT BREAST-CANCER TRIAL COMPARING CONVENTIONAL WITHPERIOPERATIVE INITIATION OF CHEMOTHERAPY
Authors: KRAINER M BRODOWICZ T SEVELDA P WILTSCHKE C SMITH T SCHOLTEN C SEIFERT M DADAK C MAROSI C KUBISTA E ZIELINSKI CC
Citation: M. Krainer et al., A RANDOMIZED ADJUVANT BREAST-CANCER TRIAL COMPARING CONVENTIONAL WITHPERIOPERATIVE INITIATION OF CHEMOTHERAPY, The Cancer journal, 10(2), 1997, pp. 106-111
BIOLOGICAL CONSEQUENCES OF MODULATION OF DEFECTIVE EXPRESSION OF ICAM-1 BY TUMOR-NECROSIS-FACTOR ON BREAST-CANCER CELLS IN-VITRO
Authors: ZIELINSKI CC BUDINSKY AC BRODOWICZ T CZERWENKA K KRAINER M WILTSCHKE C
Citation: Cc. Zielinski et al., BIOLOGICAL CONSEQUENCES OF MODULATION OF DEFECTIVE EXPRESSION OF ICAM-1 BY TUMOR-NECROSIS-FACTOR ON BREAST-CANCER CELLS IN-VITRO, Experimental hematology, 25(8), 1997, pp. 106-106
TISSUE EXPRESSION AND SERUM LEVELS OF HER-2 NEU IN PATIENTS WITH BREAST-CANCER/
Authors: KRAINER M BRODOWICZ T ZEILLINGER R WILTSCHKE C SCHOLTEN C SEIFERT M KUBISTA E ZIELINSKI CC
Citation: M. Krainer et al., TISSUE EXPRESSION AND SERUM LEVELS OF HER-2 NEU IN PATIENTS WITH BREAST-CANCER/, Oncology, 54(6), 1997, pp. 475-481
DIFFERENTIAL CONTRIBUTIONS OF BRCA1 AND BRCA2 TO EARLY-ONSET BREAST-CANCER
Authors: KRAINER M SILVAARRIETA S FITZGERALD MG SHIMADA A ISHIOKA C KANAMARU R MACDONALD DJ UNSAL H FINKELSTEIN DM BOWCOCK A ISSELBACHER KJ HABER DA
Citation: M. Krainer et al., DIFFERENTIAL CONTRIBUTIONS OF BRCA1 AND BRCA2 TO EARLY-ONSET BREAST-CANCER, The New England journal of medicine, 336(20), 1997, pp. 1416-1421
DETECTION OF HETEROZYGOUS TRUNCATING MUTATIONS IN THE BRCA1 AND APC GENES BY USING A RAPID SCREENING ASSAY IN YEAST
Authors: ISHIOKA C SUZUKI T FITZGERALD M KRAINER M SHIMODAIRA H SHIMADA A NOMIZU T ISSELBACHER KJ HABER D KANAMARU R
Citation: C. Ishioka et al., DETECTION OF HETEROZYGOUS TRUNCATING MUTATIONS IN THE BRCA1 AND APC GENES BY USING A RAPID SCREENING ASSAY IN YEAST, Proceedings of the National Academy of Sciences of the United Statesof America, 94(6), 1997, pp. 2449-2453
SOLUBLE HER-2 NEU NEUTRALIZES BIOLOGIC EFFECTS OF ANTI-HER-2/NEU ANTIBODY ON BREAST-CANCER CELLS IN-VITRO/
Authors: BRODOWICZ T WILTSCHKE C BUDINSKY AC KRAINER M STEGER GG ZIELINSKI CC
Citation: T. Brodowicz et al., SOLUBLE HER-2 NEU NEUTRALIZES BIOLOGIC EFFECTS OF ANTI-HER-2/NEU ANTIBODY ON BREAST-CANCER CELLS IN-VITRO/, International journal of cancer, 73(6), 1997, pp. 875-879
DECREASED EXPRESSION OF ICAM-1 AND ITS INDUCTION BY TUMOR-NECROSIS-FACTOR ON BREAST-CANCER CELLS IN-VITRO
Authors: BUDINSKY AC BRODOWICZ T WILTSCHKE C CZERWENKA K MICHL I KRAINER M ZIELINSKI CC
Citation: Ac. Budinsky et al., DECREASED EXPRESSION OF ICAM-1 AND ITS INDUCTION BY TUMOR-NECROSIS-FACTOR ON BREAST-CANCER CELLS IN-VITRO, International journal of cancer, 71(6), 1997, pp. 1086-1090
FREQUENCY OF RECURRENT BRCA1 AND BRCA2 MUTATIONS IN ASHKENAZI JEWISH BREAST-CANCER FAMILIES
Authors: TONIN P WEBER B OFFIT K COUCH F REBBECK TR NEUHAUSEN S GODWIN AK DALY M WAGNERCOSTALOS J BERMAN D GRANA G FOX E KANE MF KOLODNER RD KRAINER M HABER DA STRUEWING JP WARNER E ROSEN B LERMAN C PESHKIN B NORTON L SEROVA O FOULKES WD LYNCH HT LENOIR GM NAROD SA GARBER JE
Citation: P. Tonin et al., FREQUENCY OF RECURRENT BRCA1 AND BRCA2 MUTATIONS IN ASHKENAZI JEWISH BREAST-CANCER FAMILIES, Nature medicine, 2(11), 1996, pp. 1179-1183
PHYSICAL MAP AND COSMID CONTIG ENCOMPASSING A NEW INTERSTITIAL DELETION OF THE X-LINKED LYMPHOPROLIFERATIVE SYNDROME REGION
Authors: LAMARTINE J NICHOLS KE YIN L KRAINER M HEITZMANN F BERNARD A GAUDI S LENOIR GM SULLIVAN JL IKEDA JE PORTA G SCHLESSINGER D ROMEO G HABER DA SYLLA BS HARKIN DP
Citation: J. Lamartine et al., PHYSICAL MAP AND COSMID CONTIG ENCOMPASSING A NEW INTERSTITIAL DELETION OF THE X-LINKED LYMPHOPROLIFERATIVE SYNDROME REGION, European journal of human genetics, 4(6), 1996, pp. 342-351
GERM-LINE BRCA1 MUTATIONS IN JEWISH AND NON-JEWISH WOMEN WITH EARLY-ONSET BREAST-CANCER
Authors: FITZGERALD MG MACDONALD DJ KRAINER M HOOVER I ONEIL E UNSAL H SILVAARRIETO S FINKELSTEIN DM BEERROMERO P ENGLERT C SGROI DC SMITH BL YOUNGER JW GARBER JE DUDA RB MAYZEL KA ISSELBACHER KJ FRIEND SH HABER DA
Citation: Mg. Fitzgerald et al., GERM-LINE BRCA1 MUTATIONS IN JEWISH AND NON-JEWISH WOMEN WITH EARLY-ONSET BREAST-CANCER, The New England journal of medicine, 334(3), 1996, pp. 143-149
IN-VIVO ADMINISTRATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GRANULOCYTE-COLONY-STIMULATING FACTOR INCREASES NEUTROPHIL OXIDATIVE BURST ACTIVITY
Authors: WILTSCHKE C KRAINER M NANUT M WAGNER A LINKESCH W ZIELINSKI CC
Citation: C. Wiltschke et al., IN-VIVO ADMINISTRATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GRANULOCYTE-COLONY-STIMULATING FACTOR INCREASES NEUTROPHIL OXIDATIVE BURST ACTIVITY, Journal of interferon & cytokine research, 15(3), 1995, pp. 249-253
INCREASE OF BONE-MARROW CELLULARITY DURING ERYTHROPOIETIN TREATMENT IN MYELOMA
Authors: LUDWIG H CHOTT A FRITZ E KRAINER M
Citation: H. Ludwig et al., INCREASE OF BONE-MARROW CELLULARITY DURING ERYTHROPOIETIN TREATMENT IN MYELOMA, Stem cells, 13, 1995, pp. 77-87
TISSUE EXPRESSION AND SERUM LEVELS OF HER-2 NEU IN PATIENTS WITH BREAST-CANCER/
Authors: BRODOWICZ T KRAINER M ZEILLINGER R BUDINSKY AC WILTSCHKE C ZIELINSKI CC
Citation: T. Brodowicz et al., TISSUE EXPRESSION AND SERUM LEVELS OF HER-2 NEU IN PATIENTS WITH BREAST-CANCER/, European journal of cancer, 31A, 1995, pp. 657-657
FAILURE TO CONFIRM PRESENCE OF SV40 SEQUENCES IN HUMAN TUMORS
Authors: KRAINER M SCHENK T ZIELINSKI CC MULLER C
Citation: M. Krainer et al., FAILURE TO CONFIRM PRESENCE OF SV40 SEQUENCES IN HUMAN TUMORS, European journal of cancer, 31A(11), 1995, pp. 1893-1893
INFLUENCE OF IN-VIVO ADMINISTRATION OF GM-CSF AND G-CSF ON MONOCYTE CYTOTOXICITY
Authors: WILTSCHKE C KRAINER M WAGNER A LINKESCH W ZIELINSKI CC
Citation: C. Wiltschke et al., INFLUENCE OF IN-VIVO ADMINISTRATION OF GM-CSF AND G-CSF ON MONOCYTE CYTOTOXICITY, Experimental hematology, 23(5), 1995, pp. 402-406
CURRENT STATUS OF DIAGNOSTICS AND THERAPE UTICS OF MALIGNANT DISEASES- THE ROLE OF ADHESION MOLECULES IN ONCOLOGY
Authors: BUDINSKY AC WILTSCHKE C BRODOWICZ T KRAINER M DJAVANMARD MP ZIELINSKI CC
Citation: Ac. Budinsky et al., CURRENT STATUS OF DIAGNOSTICS AND THERAPE UTICS OF MALIGNANT DISEASES- THE ROLE OF ADHESION MOLECULES IN ONCOLOGY, Wiener Klinische Wochenschrift, 107(15), 1995, pp. 443-450
GENETIC PREDISPOSITION FOR BREAST-CANCER - REVIEW OF THE MOLECULAR-GENETIC ASPECTS OF A WELL-KNOWN EPIDEMIOLOGIC OBSERVATION
Authors: KRAINER M ZOJER N HUBER H MANNHALTER C
Citation: M. Krainer et al., GENETIC PREDISPOSITION FOR BREAST-CANCER - REVIEW OF THE MOLECULAR-GENETIC ASPECTS OF A WELL-KNOWN EPIDEMIOLOGIC OBSERVATION, Geburtshilfe und Frauenheilkunde, 55(7), 1995, pp. 73-76
NATURAL-KILLER-CELL ACTIVITY IN LONG-TERM SURVIVORS OF TESTICULAR CANCER - INFLUENCE OF CYTOSTATIC THERAPY AND INITIAL-STAGE OF DISEASE
Authors: KRAINER M WOLF H MICHL I WILTSCHKE C BUDINSKY A KAIDER A KRATZIK C EIBL MM ZIELINSKI CC
Citation: M. Krainer et al., NATURAL-KILLER-CELL ACTIVITY IN LONG-TERM SURVIVORS OF TESTICULAR CANCER - INFLUENCE OF CYTOSTATIC THERAPY AND INITIAL-STAGE OF DISEASE, Cancer, 75(2), 1995, pp. 539-544
REDUCED MITOGENIC STIMULATION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS AS A PROGNOSTIC PARAMETER FOR THE COURSE OF BREAST-CANCER - A PROSPECTIVE LONGITUDINAL-STUDY
Authors: WILTSCHKE C KRAINER M BUDINSKY AC BERGER A MULLER C ZEILLINGER R SPEISER P KUBISTA E EIBL M ZIELINSKI CC
Citation: C. Wiltschke et al., REDUCED MITOGENIC STIMULATION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS AS A PROGNOSTIC PARAMETER FOR THE COURSE OF BREAST-CANCER - A PROSPECTIVE LONGITUDINAL-STUDY, British Journal of Cancer, 71(6), 1995, pp. 1292-1296
GENETIC PREDISPOSITION FOR BREAST-CANCER - FROM EPIDEMIOLOGIC STUDIESTO MOLECULAR-GENETICS
Authors: KRAINER M
Citation: M. Krainer, GENETIC PREDISPOSITION FOR BREAST-CANCER - FROM EPIDEMIOLOGIC STUDIESTO MOLECULAR-GENETICS, Onkologie, 17(5), 1994, pp. 470-477
TESTICULAR CANCER - STATE-OF-THE-ART
Authors: KRAINER M KUHRER I KRATZIK C
Citation: M. Krainer et al., TESTICULAR CANCER - STATE-OF-THE-ART, Wiener Klinische Wochenschrift, 106(2), 1994, pp. 37-44
Risultati: 1-25 | 26-26